The retinoblastoma tumor suppressor gene product (Rb) binds directly to the largest TFIID subunit, TATAbinding protein associated factor TAF II 250, ®rst identi®ed as the cell cycle regulatory protein CCG1. Here we map the domains in Rb and TAF II 250 important for their interaction in vitro and in vivo. Both the amino terminus and the large pocket of Rb are able to associate independently with TAF II 250. The binding domain(s) within the large pocket are distinct from the viral oncoprotein and E2F binding region since certain pocket mutations, which abolish E1A binding, do not abolish TAF II 250 binding. Consistent with the large pocket of Rb binding to TAF II 250, the large pocket domains of both p107 and p130 are able to bind to TAF II 250 in vivo. We also demonstrate that at least two regions of TAF II 250 are able to bind to the large pocket of Rb independently whereas the amino terminus of Rb binds to a distinct domain in TAF II 250. We further demonstrate that Rb can bind to TFIID in vitro, presumably in part through an interaction with TAF II 250. Our results suggest a complex interaction between Rb and TAF II 250 and imply that TAF II 250, TFIID, and potentially other basal transcription factors are targets for regulation by Rb and Rb-related proteins.
Introduction
The retinoblastoma susceptibility gene product Rb is a tumor suppressor whose inactivation is associated with the etiology of a subset of human tumors . Although the exact mechanism through which Rb acts as a tumor suppressor is unclear, Rb has been shown to regulate transcription in a cell cycle dependent manner through interactions with speci®c transcription factors (Chellappan et al., 1991; Gu et al., 1993; Hagemeier et al., 1993; Kim et al., 1992a,b; Rustgi et al., 1991; Wang et al., 1993) . In particular, Rb is able to bind either directly or indirectly in vivo to E2F Kaelin et al., 1992; Shan et al., 1992) Elf-1 , MyoD (Gu et al., 1993) and ATF-2 (Kim et al., 1992b) as well as other transcription factors to regulate their transcription activity in either a negative or positive manner.
However, recent experiments suggest that the interaction of Rb with E2F serves to target Rb to the promoter, in addition to repressing E2F-mediated transcription (Adnane et al., 1995; Bremner et al., 1995; Sellers et al., 1995; Weintraub et al., 1995) . Thus it is possible that Rb is able to regulate transcription through additional interactions once it is brought to the promoter complex through an interaction with E2F and/or other transcription factors. In addition, Rb is able to modulate the transcriptional activity of certain transcription factors such as Sp1 (Kim et al., 1992b; Udvadia et al., 1993) , independent of a direct association.
A central component of the eukaryotic transcription machinery is TFIID, a complex consisting of the TATA-binding protein (TBP) and at least seven TBPassociated factors (TAFs) which are required for activated gene expression (Goodrich and Tjian, 1994) . TAF II 250, the largest subunit of TFIID, binds directly to TBP as well as several other TAFs including TAF II 40, TAF II 60, and TAF II 150 (Chen et al., 1994; Ruppert et al., 1993) . TAF II 250 has been shown to be necessary for conferring transcription mediated by p53 through TAF II 40 and TAF II 60 (Thut et al., 1995) , by NF-1 through TAF II 150 and by Sp1 through TAF II 110 in vitro (Chen et al., 1994) . A temperature-sensitive mutation in TAF II 250, originally termed CCG1 for cell cycle gene 1, in the Syrian hamster cell line, ts13, results in G1 arrest at the non-permissive temperature (Hayashida et al., 1994) . Presumably this cell cycle block is the consequence of TAF II 250-mediated alterations in gene expression of certain cell cycle control genes (Wang and Tjian, 1994) . Thus TAF II 250 is important not only for the regulation of transcription but also the cell cycle and possibly apoptosis (Sekiguchi et al., 1995) . Recently, we have shown that Rb can bind directly to TAF II 250 both in vitro and in vivo (Shao et al., 1995) and that stimulation of Sp1-mediated transcription by Rb is conferred through a TAF II 250-dependent pathway. These results suggest that TAF II 250 is an important target for regulation by Rb.
In order to understand how the association of Rb with TAF II 250 regulates transcription and possibly the cell cycle, we have mapped the domains in Rb and TAF II 250 important for their interaction using both in vitro and in vivo assays. Our results demonstrate that there are at least two domains in Rb and TAF II 250 important for their association. In addition, we have shown that Rb is able to associate with TFIID, presumably through its interaction with TAF II 250. Taken together, our results demonstrate that Rb can interact with certain transcription factors and TAF II 250/TFIID through dierent domains, suggesting that Rb might be able to interact with speci®c transcription factors and TFIID simultaneously.
Results

Mapping of the domains in Rb important for binding TAF II 250 in vivo
We have previously shown that TAF II 250 can bind both to Rb and a GAL4-Rb fusion in vivo . The use of the GAL4 DNA binding domain as an epitope allows for comparison of the relative binding of dierent Rb mutants as well as dierent proteins. Therefore, to map the domains in Rb important for binding TAF II 250 in vivo, a series of non-overlapping deletions in Rb were fused to the GAL4 DNA binding domain ( Figure 1a) . All of the GAL4-Rb mutants were expressed as the expected size and at a similar level following transfection of C-33A cells, as determined by Western analysis using a GAL4 antibody (Figure 1c ). In addition, the GAL4-Rb proteins with intact small pocket regions were shown to be functional in that they could interact with E1A, targeting it to the GAL4-dependent promoter in the G5BCAT reporter plasmid to stimulate transcription ( Figure 1d ) (Adnane et al., 1995) . These GAL4-Rb constructs were cotransfected into C-33A cells with an HA-tagged TAF II 250 expression vector, extracts prepared 48 h post-transfection, and immunoprecipitated with a GAL4-antibody. The presence of co-immunoprecipitated HA-TAF II 250 was detected by immunoblotting using an anti-HA antibody. As is shown in Figure 1b , none of the small deletions abolished the ability of GAL4-Rb to bind to TAF II 250, although there was some variation in binding.
The inability to identify a deletion in Rb which abolishes binding to TAF II 250 suggests that multiple domains in Rb are important for binding to TAF II 250. To determine if multiple domains are indeed involved in binding TAF II 250, GAL4-Rb fusion proteins were generated which contain speci®c regions of Rb ( Figure  2a ). These GAL4-Rb proteins were all expressed at the expected sizes and at similar levels following transfection of C-33A cells (data not shown). Analysis of binding of the dierent fragments of Rb to TAF II 250 in vivo showed that two non-overlapping domains of Rb, 10 ± 308 and 394 ± 774, were able to bind to TAF II 250 independently (Figure 2b ). GAL4-Rb mutants that only contain either domain A or B of the pocket or only the C-terminal region were signi®cantly reduced in their ability to associate with TAF II 250. The introduction of two naturally occurring mutations, C706F and J82 (D703 ± 737) (Horowitz et al., 1989) , into the pocket region of Rb partially reduced the binding to TAF II 250 (data not shown). However, domain B plus the C-terminal region (649 ± 928) bound only weakly to TAF II 250 (data not shown). Although the C-terminal region alone could not bind to TAF II 250, the observation that GAL4-Rb (295 ± 928) binds with a higher anity to TAF II 250 compared to GAL4-Rb (394 ± 774) suggests that sequences within Results are presented as relative fold-activation of CAT reporter gene transcription, with SVE set to 1. *GAL4-Rb(295 ± 928) has been shown to interact with E1A (Liu and Green, 1990) the carboxy terminus are contributing to binding. In addition, deletion of amino acids 817 ± 839 impairs the ability of GAL4-Rb to associate with TAF II 250 (see Figure 1b ), further suggesting a role for the C-terminus of Rb. Overall, these results suggest that within the large pocket of Rb, domains A, B and the C-terminus of Rb can each contribute to the interaction with TAF II 250 and that at least two of these domains are required for low level binding.
p107 and p130 bind to TAF II 250
The mapping results demonstrate that the large pocket of Rb as well as the small pocket can bind to TAF II 250. To determine if the Rb-related pocket proteins p107 (Ewen et al., 1991; Zhu et al., 1993) and p130 (Hannon et al., 1993; Li et al., 1993) can bind to TAF II 250 in vivo, GAL4-p107 and GAL4-p130 expression vectors ( Figure 3a ) were cotransfected with a TAF II 250 expression vector into C-33A cells. Extracts from the transfected cells were immunoprecipitated with a GAL4 antibody and subjected to Western analysis using an HA antibody to detect HA-TAF II 250 and a GAL4 antibody to determine levels of GAL4-fusion protein. As shown in Figure 3b , TAF II 250 was coimmunoprecipitated with the Rb, p107 and p130 GAL4 fusion proteins, but not with a GAL4-Sp1 fusion control. The reduced level of TAF II 250 coimmunoprecipitated with GAL4-p130 re¯ects in part the reduced level of expression of the fusion protein (Figure 3c ), but also may re¯ect either a reduced anity of p130 for TAF II 250, or the fact that the GAL4-p130 tested was not full-length. These results suggest that Rb, p107, and p130, all containing the conserved pocket domain, bind to and possibly regulate TAF II 250 function.
Mapping of the domains in Rb important for binding TAF II 250 in vitro
To con®rm the observed in vivo binding of Rb to TAF II 250 using an in vitro assay, the ability of dierent weakly, and 1 ± 88 did not bind at all (Figure 4b , lanes 5 and 6). Similarly, a GST-Rb (10 ± 330) fusion protein was able to bind to the TAF II 250 as eciently as GSTRb (10 ± 308) (data not shown).
Mapping the domains in TAF II 250 important for binding Rb in vitro TAF II 250 is a large protein able to bind to a number of other TAFs as well as TBP (Chen et al., 1994; Ruppert et al., 1993) , RAP74 (Ruppert and Tijan, 1995) and adenovirus E1A (Geisberg et al., 1995) . To map the Rb-binding domain(s) in TAF II 250, a series of Nterminal and C-terminal deletions in TAF II 250 were used ( Figure 5a ). The mutant TAF II 250 proteins were expressed in vitro as 35 S-labeled proteins and used for analysis of binding to GST-Rb constructs. As is shown in Figure 5b , both N434 and DN450 bound to the large pocket of Rb [GST-Rb (379 ± 928)], suggesting that two separate domains in TAF II 250 are able to bind to Rb. Minimal sequences in TAF II 250 able to bind the large pocket of Rb map between amino acids 215 and 434 as well as to a region C-terminal to amino acid 700 to just beyond 1120, although sequences outside these regions could be contributing to binding. In contrast, the amino terminus of Rb (10 ± 308) is unable to bind to the amino terminus of TAF II 250. However, it does bind to a region in TAF II 250 between amino acids 700 and 1120, possibly overlapping the binding domain for Rb's large pocket.
Rb binds to TFIID in vitro
The above results demonstrate that Rb interacts with TAF II 250 both in vivo and in vitro through multiple domains in each protein. However, the experiments do not address whether Rb can interact with TAF II 250 when it is part of the TFIID complex. To determine if Rb can interact with TFIID, the TFIID complex was immunopuri®ed from HeLa cells with either anti-TBP or anti-TAF II 70. Immobilized TFIID immunocomplex was then incubated with extract containing Rb expressed from baculovirus-infected Sf9 cells, and bound proteins were eluted and analysed by immunoblotting with anti-Rb. As is shown in Figure 6 , Rb is able to associate with immunopuri®ed TFIID (lanes 3 and 5).
To further demonstrate that Rb can associate with TFIID in vitro, extract from C-33A cells (stably expressing HA-tagged TBP) (Shao, 1995) was incubated with various GST-Rb fusion proteins that were immobilized on glutathione-Sepharose beads. The bound proteins were eluted and analysed by immunoblotting using antibodies against TAF II 250 and TAF II 70. Rb was demonstrated previously not to bind directly to TAF II 70 in vitro . As is shown in Figure 7 , TAF II 70 was found associated only with those GST-Rb proteins which also bound TAF II 250 (lanes 4 and 5), and at a similar level of binding relative to the input controls (lanes 1 and 2) . GST-Rb (10 ± 308) was able to associate weakly with TAF II 70 (data not shown). In addition, HA-tagged TBP was also shown to be associated with these same GST-Rb proteins and, again, at a binding level similar to that seen for binding to TAF II 250, relative to the input controls (data not shown). Since Rb doesn't bind to either TBP or TAF II 70 directly in vitro, this result is consistent with Rb associating with TAF II 70 (and TBP) indirectly through their interaction with TAF II 250 within TFIID. It is important to note, however, that it is formally possible that Rb is interacting with TFIID through a TFIID-associated protein in vitro and in vivo.
Discussion
TAF II 250 is a component of TFIID, which is required for activated transcription from Pol II-dependent promoters (Chen et al., 1994) . In addition to binding TBP and other TAFs, TAF II 250 has also been shown to bind the RAP74 subunit of TFIIF (Ruppert and Tijan, 1995) , as well as adenovirus E1A (Geisberg et al., 1995) and HSV-ICP4 (Carrozza and DeLuca, 1996) . We have previously demonstrated that Rb can associate with TAF II 250, regulating Sp1-mediated transcription . In this report we have examined the regions in TAF II 250 and Rb Methods were the same as described above for b, except 100 mg of extract from 293 cells was used, and retention of adenovirus E1A by GST-Rb proteins was detected with anti-E1A (M73). 20% and 5% input lanes represent 20 mg and 5 mg, respectively, of 293 cell extract important for their association. Our results suggest that there are multiple domains in Rb and TAF II 250 important for their interaction both in vivo and in vitro. The large pocket of Rb and a region between amino acids 10 ± 308 in the amino terminus bind eciently to TAF II 250. Binding of the large pocket, however, is not dramatically aected by mutations in domain B of the large pocket, such as 706 or J82. In contrast, these mutations dramatically aect binding of viral oncoproteins such as E1A and SV40 T-antigen, as well as the transcription factor E2F (Hiebert et al., 1992; Hu et al., 1990; Huang et al., 1990; Qian et al., 1992; Qin et al., 1992) . Thus it appears as if the binding of TAF II 250 by Rb requires a dierent region(s) of the large pocket than do other conventional pocket-binding proteins. Given that it has already been shown that Rb can interact with multiple transcription factors simultaneously (Weintraub et al., (Dryja et al., 1993; Hogg et al., 1993) . There appear to be at least two domains in TAF II 250 important for binding the large pocket of Rb (Figure 8 ). One domain is found within the amino terminus of TAF II 250, whereas the second lies near to or overlaps with the RAP74 (Ruppert and Tijan, 1995) and E1A binding domains (Geisberg et al., 1995) . The mapping analysis demonstrates that the large pocket of Rb can bind to both of these domains in TAF II 250, but that the amino terminus of Rb is unable to bind to the amino terminus of TAF II 250. Whether the amino terminus of Rb binds to the same region between amino acids 700 and 1120 as the large pocket or to a distinct region is unclear. These results demonstrate that the interaction between Rb and TAF II 250 is complex and suggests that Rb may have multiple eects on transcription conferred by TAF II 250.
As yet, it remains unclear as to how the association of Rb with TAF II 250 regulates transcription. We have previously shown that the regulation of Sp1-mediated transcription is mediated in part through TAF II 250 . Moreover, we have also shown that the ability of Rb to repress E2F-mediated transcription is partially alleviated in ts13 cells at the non-permissive temperature. Thus the TAF II 250-Rb interaction may be important for regulation of transcription conferred by multiple transcription factors. It is possible that Rb can aect the conformation of TAF II 250 and/or aect the binding of TAF II 250 to other factors. One of the regions in TAF II 250 important for binding Rb maps to a domain near or overlapping with the binding domain for the RAP74 subunit of TFIIF (Ruppert and Tijan, 1995) . Preliminary experiments suggest that Rb competes with RAP74/TFIIF for binding to TAF II 250. The binding domains within TAF II 250 for either the large pocket or the amino terminus of Rb may also overlap with the binding domains of other TAFs, thus aecting their association. Another possibility is that Rb-binding alters the conformation of TAF II 250, aecting its ability to confer transcription directly.
We also have demonstrated that Rb can associate with TFIID. Although we have not demonstrated that the association of Rb with TFIID is through TAF II 250, given the ability of Rb to bind TAF II 250 more eciently than the other TAFs , it is likely that TAF II 250 is the target in TFIID for Rb binding. Thus the domains in TAF II 250 for Rb binding appear to be exposed in the context of TFIID, similar to what was observed for RAP74 binding to TFIID (Ruppert and Tijan, 1995) . We further have shown that the amino terminus and large pocket of Rb can bind independently of one another to both TAF II 250 and TFIID. These results suggest that not only can Rb interact with speci®c transcription factors such as E2F, but it can also interact with at least one basal transcription factor, TFIID. It is important to note that the ability of Rb to bind TFIID is in contrast to a previous report using GST-Rb and puri®ed TFIID that did not observe a direct interaction (Weintraub et al., 1995) . Indeed, it has been reported that Rb blocked the interaction of speci®c transcription factors with TFIID (Weintraub et al., 1995) . The reason for the discrepancy in results may re¯ect dierences in either the assays used (e.g. signi®cant dierences in binding buer salt concentrations), the integrity of the TFIID, or the anity of Rb for TAF II 250 and for certain transcription factors. We also have demonstrated that the large pockets of p107 and p130 can also bind to TAF II 250 in vitro. However, in contrast to Rb, the amino terminus of p107 is unable to bind to either TAF II 250 or TFIID in vitro (data not shown). Moreover, the regulation of Sp1-mediated transcription by p107 is dierent than the regulation by Rb (Datta et al., 1995) . Thus p107 and/or p130 may regulate TAF II 250 activity through a direct association, but in a manner dierent than Rb. Clearly, further studies are necessary to understand how the complex interactions between TAF II 250 and Rb as well as other pocket proteins aect transcription, the cell cycle and possibly apoptosis.
Materials and methods
Plasmid constructs
The GAL4-RB plasmid expresses wild type human Rb fused in-frame to the GAL4 DNA-binding domain (aa 1 ± 147) within the pSG424 vector . and all GAL4-Rb small internal deletion mutants were made by replacing wt-Rb(10 ± 928) in pSG424 with the respective mutant Rb sequences from SVE-Rb mutants (Adnane et al., 1995) . GAL4-Rb(10 ± 308) was made from GAL4-Rb(dl 309 ± 343) by taking advantage of a unique XhoI site at the deletion position and an EagI site at the position corresponding to aa 10 of Rb. GAL4-Rb(394 ± 572), (394 ± 774) and (774 ± 928) were made by PCR ampli®cation from the human Rb expression vector and then cloned into pSG424. GAL4-Rb(295 ± 928) was provided by Dr MR Green (Liu and Green, 1990 ) and GAL4-p107 provided by Dr J Adnane. GAL4-p130(322 ± 1139) was made by inserting the 3.5 kb XbaI(blunt-ended) fragment of p130 (in pBlueScript) (Mayol et al., 1993) into BamHI(blunt-end) site of pSG424. The GAL4-Sp1 fusion plasmid (G-Sp1N) and the G5BCAT reporter construct were provided by Dr G Gill (Kim et al., 1992a) . GSTRb(379 ± 928) and (379 ± 928, 706) were provided by Dr W Kaelin (Kaelin et al., 1991) . and (10 ± 308) were made by inserting the respective fragments from GAL4-fusion constructs into the SmaI site of pGEX-2T (Pharmacia). GST-Rb(1 ± 88) and (1 ± 202) were made by PCR ampli®cation from a human Rb expression vector and cloned into pGEX-2T (BamHI/EcoRI sites). Human TAF II 250 with an HA epitope tag was expressed from a CMV expression vector (Wang and Tjian, 1994) . All human TAF II 250 constructs, including TAF II 250 mutants in a T7 expression vector, as well as both Rb and TAF II 250 baculovirus, were described previously (Dikstein et al., 1996; Dowdy et al., 1993; Ruppert and Tijan, 1995) .
Immunoprecipitation and Western blot analysis
Sixteen micrograms of GAL4-fusion plasmid was cotransfected with 8 mg of CMV-HA-hTAF II 250 into 6610 5 C-33A cells by calcium phosphate precipitation. Two days after transfection, cells were lysed in 1 mL EBC-D [50 mM Tris-HCl, pH 8.0; 170 mM NaCl; 0.5% NP-40; 1 mM DTT; 50 mM NaF; leupeptin (1 mg/ml); aprotinin (1 mg/ml); PMSF (50 mg/ml)]. After clari®cation, half of the cell lysates were incubated with anti-GAL4 (Upstate Biotechnology) at 48C O/N. Protein A-Sepharose was then included (20 mL of 50% slurry v:v in EBC-D) for another 2 h at 48C. Immunocomplexes were then pelleted by centrifugation and washed 36 with 200 mM NaCl buer (10 mM Tris-HCl, pH 8.0; 200 mM NaCl; 5 mM EDTA; 0.5% NP-40; 1 mM DTT). Samples were boiled in 16 Laemmli sample buer, subjected to SDS ± PAGE and then analysed by immunoblotting with either anti-HA (12CA5) (Templeton et al., 1991) to detect HA-TAF II 250 or with anti-GAL4 to detect relative levels of GAL4-fusion protein.
For detection of TFIID-bound Rb in vitro, human TFIID was immunopuri®ed from HeLa nuclear extracts using polyclonal anti-TBP (Tanese et al., 1991) and anti-human TAF II 70 (SR unpublished). Complexes were analysed by SDS ± PAGE and silver staining. Extracts from recombinant baculovirus expressing Rb in Sf9 cells were prepared as described (Ruppert et al., 1993) . After clearing the Rb/Sf9 extract by centrifugation, it was incubated with immunopuri®ed TFIID for 11 h at 48C in 0.1 M KCl-HEMGN (0.1M KCl, 25 mM HEPES, 12.5 mM MgCl 2 0.1 mM EDTA, 20% glycerol, 0.1% NP-40, 1 mM DTT, 0.2 mM PMSF (phenylmethylsulfonyl¯uoride) and 0.1 mM sodium metabisul®te). After extensive washing, bound proteins were analysed by SDS ± PAGE followed by Western blotting using monoclonal anti-Rb (IF8, Santa Cruz Biotech.) and detection using ECL (Amersham).
GST-Rb binding assays
GST-fusion proteins were expressed in E. coli, bound to glutathione-Sepharose 4B beads (Pharmacia) and incubated with the appropriate cell extract or labeled protein. For mapping domains in GST-Rb constructs responsible for interacting with TAF II 250, GST or GST-Rb proteins were incubated with 3 mg of extract from Sf9 cells infected with HA-hTAF II 250 baculovirus, in 250 ml of 200 mM NaCl buer plus 3 mg/ml BSA and protease inhibitors (1 mg/ml each leupeptin and aprotinin, 50 mg/ml PMSF). Binding was at RT for 1 h, with constant rotation, followed by ®ve washes with 1 ml of 200 mM NaCl buer. Bound proteins were boiled in 16 Laemmli sample buer, separated by SDS ± PAGE and analysed for the presence of TAF II 250 by Western using anti-HA (12CA5). To investigate Rb's association with TFIID, GST-Rb proteins were incubated with 100 mg of C-33A(eTBP) cell extract, in 250 ml of Buer 1 (10 mM HEPES, pH 7.4; 200 mM NaCl; 0.5 mM EDTA; 0.5 mM DTT; 0.1% NP-40) plus protease inhibitors and BSA. Conditions for binding were the same as above and SDS ± PAGE-separated proteins were analysed by immunoblot using anti-TAF II 250 (6B3, Santa Cruz Biotechnology) and anti-TAF II 70 (6C1, Santa Cruz Biotech.). For mapping Rb-binding regions within TAF II 250, GST, GST-Rb (379 ± 928), and GSTRb(10 ± 308) were incubated with w.t. and deletion mutants of hTAF II 250, which were generated by in vitro transcription/ translation. One microgram of plasmid DNAs encoding the respective TAF II 250 constructs was transcribed/translated in a 50 ml reaction mixture, in the presence of [ 35 S]Met, for 90 min at 308C using a T7 coupled transcription/translation system (Promega). The labeled TAF II 250 constructs were then incubated with the above-indicated GST-fusion proteins, in 250 ml of Buer 1 plus protease inhibitors and BSA. Conditions for binding were the same as described above for other GST assays. Bound protein was separated by SDS ± PAGE and, after drying the gel, visualized by autoradiography. For comparison and quantitation, 10% of the volume of each labeled TAF II 250 construct used for binding was included on the gels. Percentage of binding was quantitated as CPMs compared to 10% input, on an AMBiS Radioanalytic Imager.
